MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant ChemotherapyAndreas-Claudius Hoffmann, Arndt Hartmann, Robert Stöhr et al.|Neoplasia|2010Cited by 137
Correlation of multidrug-resistance gene (MDR1) expression levels and outcome to adjuvant cisplatin/MTX based chemotherapy in patients enrolled in the AUO-AB 05/95 phase III trialA. C. Hoffman, Anders Hartmann, Peter J. Wild et al.|Journal of Clinical Oncology|2009Cited by 1
Use of multidrug-resistance gene (MDR1) expression levels to predict outcome to adjuvant cisplatin/gemcitabine based chemotherapy in patients with with locally advanced urothelial cancerThomas Gauler, A. Hartmann, Jens Lehmann et al.|Journal of Clinical Oncology|2009Cited by 0